These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 7473126)
21. Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing. Martin WJ; Gupta NK; Loo CM; Rohde DS; Basbaum AI Pain; 1999 Mar; 80(1-2):57-65. PubMed ID: 10204718 [TBL] [Abstract][Full Text] [Related]
22. Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. Nishiguchi J; Sasaki K; Seki S; Chancellor MB; Erickson KA; de Groat WC; Kumon H; Yoshimura N Eur J Neurosci; 2004 Jul; 20(2):474-82. PubMed ID: 15233756 [TBL] [Abstract][Full Text] [Related]
23. Expression of blood-brain barrier characteristics following neuronal loss and astroglial damage after administration of anti-Thy-1 immunotoxin. Krum JM; Kenyon KL; Rosenstein JM Exp Neurol; 1997 Jul; 146(1):33-45. PubMed ID: 9225736 [TBL] [Abstract][Full Text] [Related]
24. Selective changes in hippocampal neuropeptide Y neurons following removal of the cholinergic septal inputs. Milner TA; Wiley RG; Kurucz OS; Prince SR; Pierce JP J Comp Neurol; 1997 Sep; 386(1):46-59. PubMed ID: 9303524 [TBL] [Abstract][Full Text] [Related]
25. Effects of hypocretin2-saporin and antidopamine-beta-hydroxylase-saporin neurotoxic lesions of the dorsolateral pons on sleep and muscle tone. Blanco-Centurion C; Gerashchenko D; Salin-Pascual RJ; Shiromani PJ Eur J Neurosci; 2004 May; 19(10):2741-52. PubMed ID: 15147308 [TBL] [Abstract][Full Text] [Related]
26. Substance P-saporin down-regulates substance P receptor immunoreactive sensory dorsal root ganglion neurons innervating the lumbar intervertebral discs in rats. Ohtori S; Inoue G; Koshi T; Ito T; Doya H; Moriya H; Takahashi K Spine (Phila Pa 1976); 2006 Dec; 31(26):2987-91. PubMed ID: 17172993 [TBL] [Abstract][Full Text] [Related]
27. Lesions of medullary catecholaminergic neurons increase salt intake in rats. Colombari DS; Pedrino GR; Freiria-Oliveira AH; Korim WS; Maurino IC; Cravo SL Brain Res Bull; 2008 Aug; 76(6):572-8. PubMed ID: 18598847 [TBL] [Abstract][Full Text] [Related]
28. Destruction of locus coeruleus neuronal perikarya after injection of anti-dopamine-B-hydroxylase immunotoxin into the olfactory bulb of the rat. Blessing WW; Lappi DA; Wiley RG Neurosci Lett; 1998 Feb; 243(1-3):85-8. PubMed ID: 9535119 [TBL] [Abstract][Full Text] [Related]
30. Retrograde transport of dopamine beta-hydroxylase antibodies in sympathetic neurons: effects of drugs modifying noradrenergic transmission. Lees GJ; Horsburgh RJ Brain Res; 1984 Jun; 301(2):281-6. PubMed ID: 6203610 [TBL] [Abstract][Full Text] [Related]
31. Effect of chronically administered nicotine on axonal transport of dopamine-beta-hydroxylase in peripheral adrenergic neurons and on blood pressure and heart rate in the rat. Häggendal J; Henning M Acta Physiol Scand Suppl; 1980; 479():35-8. PubMed ID: 6158829 [TBL] [Abstract][Full Text] [Related]
32. A2 noradrenergic neurons regulate forced swim test immobility. Nam H; Kerman IA Physiol Behav; 2016 Oct; 165():339-49. PubMed ID: 27553574 [TBL] [Abstract][Full Text] [Related]
33. Role of A5 noradrenergic neurons in the chemoreflex control of respiratory and sympathetic activities in unanesthetized conditions. Taxini CL; Moreira TS; Takakura AC; Bícego KC; Gargaglioni LH; Zoccal DB Neuroscience; 2017 Jun; 354():146-157. PubMed ID: 28461215 [TBL] [Abstract][Full Text] [Related]
34. Immune lesions of central noradrenergic nerves in the rat produced by antibodies to dopamine-beta-hydroxylase. Blessing WW; Costa M; Geffen LB; Rush RA Clin Exp Neurol; 1978; 15():307-8. PubMed ID: 756021 [No Abstract] [Full Text] [Related]
35. Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats. Lassen JB Psychopharmacologia; 1974; 37(4):331-40. PubMed ID: 4136728 [No Abstract] [Full Text] [Related]
36. [Effects of antibodies to dopamine-beta-monooxygenase on the level of catecholamines in the brain]. Pogosian AS; Boiadzhian AS; Karagezian KG; Aĭvazian VA; Movsesian AV Biull Eksp Biol Med; 1991 Aug; 112(8):133-4. PubMed ID: 1786369 [No Abstract] [Full Text] [Related]
37. Noradrenergic and neuropeptide Y mechanisms in guanethidine-sympathectomized rats. Benarroch EE; Schmelzer JD; Ward KK; Nelson DK; Low PA Am J Physiol; 1990 Aug; 259(2 Pt 2):R371-5. PubMed ID: 2386246 [TBL] [Abstract][Full Text] [Related]
38. Nucleus of the solitary tract catecholaminergic neurons modulate the cardiovascular response to psychological stress in rats. Daubert DL; McCowan M; Erdos B; Scheuer DA J Physiol; 2012 Oct; 590(19):4881-95. PubMed ID: 22753543 [TBL] [Abstract][Full Text] [Related]
39. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent. Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230 [No Abstract] [Full Text] [Related]
40. Influence of dopamine-beta-hydroxylase inhibition on the cardiovascular and respiratory actions of dopamine in rats. Riancho JA; del Arco C; Pazos A; Flórez J Rev Esp Fisiol; 1982 Dec; 38(4):461-9. PubMed ID: 7170431 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]